Biamet-TG

• • Efficacy & safety in type 2 diabetes patient complicated by CKD

• • Significantly reduced the 24-h mean sensor glucose levels & AUC 180

• • Diabetic patient with cardiovascular disease

• • Elderly diabetic patients

• • Effective and consistent glycemic control with a good tolerability profile, including no severe hypoglycemia and weight gain